Global Healthcare Analyst

Tina Banerjee

Equity Capital Markets

Manipal Health Enterprises Ltd / Equity Capital Markets

Manipal Health Enterprises Ltd (1217834D IN)

<ul>
<li>Manipal Health will launch its India IPO on July 29. The IPO consists of fresh issue of INR80B (~$829M) and OFS of up to 22M shares aggregating to INR13B.</li>
<li>The IPO price band is set at INR560 to INR590 per share. The IPO subscription will close on July 31, with expected listing on August 5.</li>
<li>Manipal Health proposes to utilize the net proceeds mainly for repayment/ prepayment of certain outstanding borrowings. As of May 31, 2026, the company had outstanding borrowings of INR112B.</li>
</ul>


Manipal Health will launch its India IPO on July 29. The IPO consists of fresh issue of INR80B (~$829M) and OFS of up to 22M shares aggregating to INR13B.
The IPO price band is set at INR560 to INR590 per share. The IPO subscription will close on July 31, with expected listing on August 5.
Manipal Health proposes to utilize the net proceeds mainly for repayment/ prepayment of certain outstanding borrowings. As of May 31, 2026, the company had outstanding borrowings of INR112B.


Manipal Health IPO: Poised for Long-Term Growth with Massive Scale and Several Margin Levers

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/manipal-health-enterprises-ltd" target="_blank" data-smartkarma-citation="entities:48013:1" rel="noopener">Manipal Health Enterprises Ltd (1217834D IN)</a>, a leading private hospital chain in India, is seeking to raise about US$1.1 billion.    </li>
<li>Founded in 2010, Manipal Hospitals focuses on key areas such as cardiology, oncology, transplants, neurosciences, orthopaedics, emergency, and critical care.</li>
<li>The investment case rests on peer-leading revenue growth driven by top-tier KPIs, headroom to sustain growth momentum, peer-leading EBITDA margins, and cash generation.</li>
</ul>



Manipal Health Enterprises Ltd (1217834D IN), a leading private hospital chain in India, is seeking to raise about US$1.1 billion.    
Founded in 2010, Manipal Hospitals focuses on key areas such as cardiology, oncology, transplants, neurosciences, orthopaedics, emergency, and critical care.
The investment case rests on peer-leading revenue growth driven by top-tier KPIs, headroom to sustain growth momentum, peer-leading EBITDA margins, and cash generation.


Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/manipal-health-enterprises-ltd" target="_blank" data-smartkarma-citation="entities:48013:1" rel="noopener">Manipal Health Enterprises</a> (MHEL) is looking to raise about US$1bn in its upcoming India IPO. </li>
<li>MHEL operates a pan‑India network of multispecialty hospitals delivering a range of care services, from outpatient services to complex tertiary and quaternary interventions.</li>
<li>In this note, we talk about the not-so-positive aspects of the deal.</li>
</ul>



Manipal Health Enterprises (MHEL) is looking to raise about US$1bn in its upcoming India IPO. 
MHEL operates a pan‑India network of multispecialty hospitals delivering a range of care services, from outpatient services to complex tertiary and quaternary interventions.
In this note, we talk about the not-so-positive aspects of the deal.


Aequitas: Manipal Hospitals Pre-IPO - The Negatives - Growth Mostly Via Acquisitons

<ul>
<li>
<a href="https://www.smartkarma.com/entities/manipal-health-enterprises-ltd" target="_blank" data-smartkarma-citation="entities:48013:1" rel="noopener">Manipal Health</a> (MHEL) is looking to raise about US$1bn in its upcoming India IPO. </li>
<li>MHEL operates a pan‑India network of multispecialty hospitals delivering a range of care services, from outpatient services to complex tertiary and quaternary interventions.</li>
<li>In this note, we talk about the positive aspects of the deal.</li>
</ul>



Manipal Health (MHEL) is looking to raise about US$1bn in its upcoming India IPO. 
MHEL operates a pan‑India network of multispecialty hospitals delivering a range of care services, from outpatient services to complex tertiary and quaternary interventions.
In this note, we talk about the positive aspects of the deal.


Aequitas: Manipal Hospitals Pre-IPO - The Positives - Strong Earnings Growth

<ul>
<li>Manipal Health has filed DRHP for its upcoming India IPO. The IPO consists of fresh issue of INR80B (~$1B) and offer for sale of up to 43M equity shares.</li>
<li>Promoter Imperius Healthcare Investments (Temasek subsidiary), promoter group Manipal Education and Medical, and investor TPG are among the selling shareholders. The IPO is expected to hit market by late 2026.</li>
<li>The company intends to utilize the net proceeds of the fresh issue for repayment/ prepayment of certain outstanding borrowings and acquisition of minority stake in stepdown subsidiary, Sahyadri Hospitals.</li>
</ul>


Manipal Health has filed DRHP for its upcoming India IPO. The IPO consists of fresh issue of INR80B (~$1B) and offer for sale of up to 43M equity shares.
Promoter Imperius Healthcare Investments (Temasek subsidiary), promoter group Manipal Education and Medical, and investor TPG are among the selling shareholders. The IPO is expected to hit market by late 2026.
The company intends to utilize the net proceeds of the fresh issue for repayment/ prepayment of certain outstanding borrowings and acquisition of minority stake in stepdown subsidiary, Sahyadri Hospitals.


Manipal Health Pre-IPO: Pai to Pie Patiently Aggressive Inorganic Growth Story Is Unfolding

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Manipal Health Enterprises Ltd (1217834D IN)

Manipal Health IPO: Poised for Long-Term Growth with Massive Scale and Several Margin Levers

Manipal Health will launch its India IPO on July 29. The IPO price band is set at INR560 to INR590 per share. The IPO subscription will close on...

Tina Banerjee

Manipal Health IPO: The Investment Case

Manipal Health, a leading private hospital chain in India, is seeking to raise about US$1.1 billion. In this note, I discuss the investment case.

Arun George

Aequitas: Manipal Hospitals Pre-IPO - The Negatives - Growth Mostly Via Acquisitons

Manipal Health Enterprises (MHEL) is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive...

Sumeet Singh

Aequitas: Manipal Hospitals Pre-IPO - The Positives - Strong Earnings Growth

Manipal Health (MHEL) is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.

Sumeet Singh

Manipal Health Pre-IPO: Pai to Pie Patiently Aggressive Inorganic Growth Story Is Unfolding

Manipal Health is looking to raise ~$1B via India IPO mainly for debt repayment. Marquee global investors Temasek and TPG will also offload partial...

Tina Banerjee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)